Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
43,659,867
-
Share change
-
-2,614,979
-
Total reported value
-
$5,124,723,578
-
Put/Call ratio
-
42%
-
Price per share
-
$117.19
-
Number of holders
-
364
-
Value change
-
-$332,051,305
-
Number of buys
-
155
-
Number of sells
-
170
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2017
As of 30 Sep 2017 UNITED THERAPEUTICS Corp - Common Stock (UTHR) had 364 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 43,659,867 shares of stock of the company.
Largest 10 holders included BlackRock Inc., FMR LLC, VANGUARD GROUP INC, AQR CAPITAL MANAGEMENT LLC, STATE STREET CORP, Palo Alto Investors, LLC, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, ACADIAN ASSET MANAGEMENT LLC, and SCHRODER INVESTMENT MANAGEMENT GROUP.
This table shows 365 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.